SCHEMBL22148643

SCHEMBL22148643

Cc1ccc2c(c1)c1cc(C)ccc1n2-c1nc(-n2c3ccc(C)cc3c3cc(C)ccc32)c(-n2c3ccc(C)cc3c3cc(C)ccc32)c(-c2ccc(-c3nc(-c4ccccc4)nc(-c4ccccc4)n3)cc2)c1-n1c2ccc(C)cc2c2cc(C)ccc21

nearest known ligand 0.38

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
L3MBTL1 Q9Y468 1/20 0.38
MEN1 O00255 4/20 0.37
KMT2A Q03164 4/20 0.37
ADORA3 P0DMS8 2/20 0.37
NLRP3 Q96P20 1/20 0.36
DHODH Q02127 1/20 0.36
ADORA2A P29274 1/20 0.36
ADORA1 P30542 1/20 0.36
NR1H2 P55055 2/20 0.36
NR1H3 Q13133 2/20 0.36
ALDH1A1 P00352 3/20 0.35
MAPT P10636 3/20 0.35
KDM4E B2RXH2 1/20 0.35
LMNA P02545 1/20 0.35
CYP1A1 P04798 1/20 0.35
CYP1A2 P05177 1/20 0.35
CYP1B1 Q16678 1/20 0.35
NR1I3 Q14994 1/20 0.35
NPC1 O15118 3/20 0.35
RAB9A P51151 3/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL22148652 0.96 MEN1 (0.37) L3MBTL1MEN1KMT2AADORA3NLRP3
SCHEMBL30709396 0.94 NR1I3 (0.40) L3MBTL1MEN1KMT2AADORA3NLRP3
SCHEMBL21888620 0.94 NLRP3 (0.40) L3MBTL1MEN1KMT2AADORA3NLRP3
SCHEMBL21562748 0.93 DHODH (0.41) L3MBTL1MEN1KMT2AADORA3NLRP3
SCHEMBL21562741 0.93 NLRP3 (0.40) L3MBTL1MEN1KMT2AADORA3NLRP3
SCHEMBL22148876 0.91 ALDH1A1 (0.39) L3MBTL1MEN1KMT2AALDH1A1MAPT
SCHEMBL21889533 0.90 MEN1 (0.38) L3MBTL1MEN1KMT2AADORA3NLRP3
SCHEMBL30338772 0.90 MEN1 (0.38) L3MBTL1MEN1KMT2AADORA3NLRP3
SCHEMBL23856002 0.90 L3MBTL1 (0.35) L3MBTL1MEN1KMT2AADORA3NLRP3
SCHEMBL31037680 0.90 L3MBTL1 (0.35) L3MBTL1MEN1KMT2AADORA3NLRP3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20200203622-A1 COMPOSITION OF MATTER FOR USE IN ORGANIC LIGHT-EMITTING DIODES KYULUX, INC. (JP) 2020-06-25 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20200203622-A1 COMPOSITION OF MATTER FOR USE IN ORGANIC LIGHT-EMITTING DIODES NDUFV3, NDUFV2, CRY2 L3MBTL1 1938/4885MEN1 2193/4885KMT2A 4367/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.